Paclitaxel drug-coated balloons (DCBs) or drug-eluting stents (DESs): Reconfirmed position on use in patients with intermittent claudication and critical limb ischaemia

Following review of new evidence, recommendations for using paclitaxel-coated devices in patients with intermittent claudication (IC) and critical limb ischaemia (CLI) remain unchanged - they should not be used in routine treatment of IC but remain an option in selected CLI cases

Medicines and Healthcare products Regulatory Agency